Credit: bioMérieux
CHICAGO, Ill. –– bioMérieux announced the incorporation of the company’s GENE-UP CAMPYLOBACTER assay into the methodology used by the U.S. Department of Agriculture Food Safety and Inspection Service (USDA-FSIS) Field Service Laboratories.
"We are thrilled to be awarded this contract by the USDA-FSIS. With the inclusion of GENE-UP CAMPYLOBACTER, bioMérieux now has the most FSIS methods of choice for microbiology than any other diagnostics provider," said Miguel Villa, senior vice president, Americas, industrial applications, bioMérieux. "This is a testament to our continued dedication to providing innovation within the animal protein sector and the food industry at large, reinforcing GENE-UP as the full solution for all molecular testing needs in one place.”
The GENE-UP CAMPYLOBACTER assay is the latest of bioMérieux’s molecular diagnostic solutions to be recognized by food safety regulatory bodies in the United States. Earlier this year, bioMérieux announced a research collaboration to improve microbial detection of foodborne pathogens with the Food and Drug Administration, and in 2022, the USDA named bioMérieux’s GENE-UP QUANT Salmonella quantification method of choice in all FSIS laboratories, with both GENE-UP QUANT Salmonella and TEMPO solutions currently included in the USDA Microbiology Laboratory Guidebook (MLG).
“Our augmented diagnostics approach helps food industry leaders go beyond the test results and harness data, genomics and diagnostic insights to solve the toughest problems,” said John Shultz, senior director, sales and marketing, industrial applications, at bioMérieux. “The recognition of GENE-UP CAMPYLOBACTER as the method of choice of the USDA is yet another way that bioMérieux helps facilitate and advance the science of food safety and protect public health.”
For more information on GENE-UP CAMPYLOBACTER, visit https://www.biomerieux.com/us/en/our-offer/industry-products/gene-up-campylobacter.html.
"We are thrilled to be awarded this contract by the USDA-FSIS. With the inclusion of GENE-UP CAMPYLOBACTER, bioMérieux now has the most FSIS methods of choice for microbiology than any other diagnostics provider," said Miguel Villa, senior vice president, Americas, industrial applications, bioMérieux. "This is a testament to our continued dedication to providing innovation within the animal protein sector and the food industry at large, reinforcing GENE-UP as the full solution for all molecular testing needs in one place.”
The GENE-UP CAMPYLOBACTER assay is the latest of bioMérieux’s molecular diagnostic solutions to be recognized by food safety regulatory bodies in the United States. Earlier this year, bioMérieux announced a research collaboration to improve microbial detection of foodborne pathogens with the Food and Drug Administration, and in 2022, the USDA named bioMérieux’s GENE-UP QUANT Salmonella quantification method of choice in all FSIS laboratories, with both GENE-UP QUANT Salmonella and TEMPO solutions currently included in the USDA Microbiology Laboratory Guidebook (MLG).
“Our augmented diagnostics approach helps food industry leaders go beyond the test results and harness data, genomics and diagnostic insights to solve the toughest problems,” said John Shultz, senior director, sales and marketing, industrial applications, at bioMérieux. “The recognition of GENE-UP CAMPYLOBACTER as the method of choice of the USDA is yet another way that bioMérieux helps facilitate and advance the science of food safety and protect public health.”
For more information on GENE-UP CAMPYLOBACTER, visit https://www.biomerieux.com/us/en/our-offer/industry-products/gene-up-campylobacter.html.
Latest from Quality Assurance & Food Safety
- FDA Bans Use of Red No. 3 in Food and Ingested Drugs
- AFDO to Host Course on Implementing Risk-Based Inspections and Auditing for Retail Food Establishments
- FDA Issues Proposed Rule on Front-of-Package Nutrition Labeling
- IAFP 2025 Registration Now Open
- Albertsons Companies Hosts Annual Competition for Emerging, Innovative Food, Beverage and Pet Products
- FDA Releases Long-Term National Strategy to Increase Resiliency of U.S. Infant Formula Market
- Extinguishing the Risk of Foodborne Illness During Wildfires
- FSIS Issues Public Health Alert for Frozen, Raw Ground Beef Products Due to Possible Foreign Matter Contamination
